Michael Murphy, MD
MOHS-Micrographic Surgery · Greenwood, INNPI 1164580973
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,849 of the $2,346 with a category attached, or 78.8%. Kerecis Limited accounts for 95.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $2,136 and has fallen 98.1% since, to $41 in 2025.
Across 10 payments — averaging $234.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- Regeneron Healthcare Solutions, Inc.$58
- Sun Pharmaceutical Industries Inc.$30
- Merck$29
What the payments were for
- Travel & lodging$1,84979%
- Food & beverage$47620%
- Education$211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 5 | $2,228 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| Merck | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 76 | $5,378 |
| Clobetasol Propionate | 34 | $1,314 |
| Fluocinonide | 30 | $874 |
| Imiquimod | 25 | $832 |
| Triamcinolone Acetonide | 94 | $817 |
| Doxycycline Hyclate | 17 | $441 |
| Cephalexin | 70 | $429 |
| Mupirocin | 38 | $416 |
| Ciprofloxacin Hcl | 22 | $143 |
| Amoxicillin | 86 | $96 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $67 |
| Tramadol Hcl | 19 | $49 |
| Clindamycin Hcl | 17 | $15 |
| Diazepam | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Greenwood
- Brian WilliamsGreenwood$5K
- Carl HankeIndianapolis$96K
- Rachel WardMuncie$9K
- Eduardo RiveraMadison$8K
- John RandallWest Lafayette$6K
- David SurprenantEvansville$5K
- Perry HooperCarmel$5K
- Shayna GordonPlainfield$4K
- Jane LimEvansville$4K
- Thomas McGovernFort Wayne$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.